H. Tilly - Publications, H-index & Citations

Back

H. Tilly

Department of Hematology

7H-index

28Paper Count

474Citation Count

Published Papers 9

Publication Date

Routine Monitoring of CAR-T-Cells Expansion and Persistence in Patients With Aggressive Large B-Cell Lymphoma by Flow Cytometry: A Single-Center Experience

Hematological Oncology

IF3.9

2025-10-07

OAAI

Alexandra Zduniak; Jérémie Martinet; Emilie Lévêque; Stéphanie Becker; David Tonnelet; Elodie Dos Santos; Claire Leroy; Mustafa Alani; Jean Rouvet; Marine Brousseau; Camille Giverne; Alexis Cuffel; Serge Jacquot; Arnaud Roucheux; Alice Veuiller; Nicolas Lecornu; Misa Eugene Norbert; Olivier Boyer; Hervé Tilly; Fabrice Jardin; Jean-Baptiste Latouche; Vincent Camus

Save

Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up

HemaSphere

IF14.6

2025-09-23

OAAI

Catherine Thieblemont; Maria Gomes Da Silva; Sirpa Leppä; Georg Lenz; Anne-Ségolène Cottereau; Christopher Fox; Armando Lopez-Guillermo; Timothy Illidge; Wojciech Jurczak; Hans Eich; Igor Aurer; Marek Trneny; Andy Andreas Rosenwald; Andrew Davies; Ben (Gerben) Zwezerijnen; Natacha Bolanos; Maja Marković; Jean-Philippe Jais; Florence Broussais; Martin Dreyling; Umberto Vitolo; Hervé Tilly; Marie-José Kersten

Save

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

Blood Advances

IF7.1

2025-03-17

OAAI

Marek Trněný; Laura Fogliatto; Faithlore Gardner; Ian Flinn; Jean-François Larouche; Corinne Haioun; Miguel Canales; Hideki Goto; Roman Hajek; Gilles Salles; Avrita Singh; Mark Yan; Rucha Kothari; Gabriel Man; Deniz Sahin; Jamie Hirata; Calvin Lee; Hervé Tilly; Christopher R. Flowers

Save

Machine learning-based prediction of germinal center, MYC/BCL2 double protein expressor status, and MYC rearrangement from whole slide images in DLBCL patients

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Syrykh, C.; Schiratti, J-B.; Brion, E.; Joubert, C.; Baia, M.; Marlot, L.; Maussion, C.; Danneaux, L. -W.; Bologna, S.; Briere, J.; Dartigues, P.; Gaulard, P.; Haioun, C.; Jardin, F.; Molina, T.; Tilly, H.; Gomez, E.; Sondaz, D.; Copie-Bergman, C.; Laurent, C.

Save

Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis

HAEMATOLOGICA

IF7.9

2015-03-06

OAAI

Bohers, Elodie; Viailly, Pierre Julien; Dubois, Sydney; Bertrand, Philippe; Maingonnat, Catherine; Mareschal, Sylvain; Ruminy, Philippe; Picquenot, Jean-Michel; Bastard, Christian; Desmots, Fabienne; Fest, Thierry; Leroy, Karen; Tilly, Herve; Jardin, Fabrice

Save

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma

HAEMATOLOGICA

IF7.9

2015-01-30

OAAI

Jordheim, Lars P.; Ribrag, Vincent; Ghesquieres, Herve; Pallardy, Sophie; Delarue, Richard; Tilly, Herve; Haioun, Corinne; Jardin, Fabrice; Demangel, Delphine; Salles, Gilles A.; Dumontet, Charles

Save

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

HAEMATOLOGICA

IF7.9

2013-06-10

151

OAAI

Mounier, Nicolas; El Gnaoui, Taoufik; Tilly, Herve; Canioni, Daniele; Sebban, Catherine; Casasnovas, Rene-Olivier; Delarue, Richard; Sonet, Anne; Beaussart, Pauline; Petrella, Tony; Castaigne, Sylvie; Bologna, Serge; Salles, Gilles; Rahmouni, Alain; Gaulard, Philippe; Haioun, Corinne

Save

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

ANNALS OF ONCOLOGY

IF65.4

2013-04-01

OAAI

Ketterer, N.; Coiffier, B.; Thieblemont, C.; Ferme, C.; Briere, J.; Casasnovas, O.; Bologna, S.; Christian, B.; Connerotte, T.; Recher, C.; Bordessoule, D.; Fruchart, C.; Delarue, R.; Bonnet, C.; Morschhauser, F.; Anglaret, B.; Soussain, C.; Fabiani, B.; Tilly, H.; Haioun, C.

Save

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up

ANNALS OF ONCOLOGY

IF65.4

2012-09-01

OAAI

Colombat, P.; Brousse, N.; Salles, G.; Morschhauser, F.; Brice, P.; Soubeyran, P.; Delwail, V.; Deconinck, E.; Haioun, C.; Foussard, C.; Sebban, C.; Tilly, H.; Thieblemont, C.; Bergougnoux, L.; Lazreg, F.; Solal-Celigny, P.

Save

Research Directions